TB-500 Tissue Repair: Protocol Comparison
Acute muscle strain 2mg twice weekly × 4 weeks 14–21 days to functional recovery Myofiber regeneration + reduced fibrosis Effective for grade 1–2 strains; grade 3 tears require surgical evaluation first Tendon injury (chronic tendinopathy) 2mg twice weekly × 6
This comparison does not assign a generated winner or score.
- Acute muscle strain
- 2mg twice weekly × 4 weeks
- 14–21 days to functional recovery
- Myofiber regeneration + reduced fibrosis
- Effective for grade 1–2 strains; grade 3 tears require surgical evaluation first
- Tendon injury (chronic tendinopathy)
- 2mg twice weekly × 6–8 weeks
- 4–6 weeks to measurable improvement
- Collagen remodeling + angiogenesis into hypovascular tissue
- Best combined with eccentric loading protocols; peptide alone insufficient
- Cardiac tissue (research models)
- 2–2.5mg twice weekly × 6 weeks
- 3–6 weeks to reduced infarct size
- Cardiomyocyte protection + border zone vascularization
- Clinical use restricted to research settings; not approved for human cardiac therapy
- Dermal wound healing
- 1.5–2mg twice weekly × 3–4 weeks
- 10–14 days to accelerated closure
- Keratinocyte migration + granulation tissue formation
- Effective for non-healing wounds; must rule out infection and vascular insufficiency